Online Support

Ask about products, research, and cooperation

Open online support for quick questions and direct answers.

Open now

Aoweisi Biotech

Synthetic biology exosome technology,
reimagining the boundaries of health care and beauty

Three product lines — skincare, intimate care, nasal care — backed by a full OEM/ODM manufacturing platform.
2023
Company founded, synthetic biology exosome platform established
Founded
3
Core product lines: skincare, intimate care, nasal care
Product Lines
98.6%
Active ingredient retention via lyophilized formulation
Active Retention
15+
Core formulation patents covering extraction, stabilization and application
Core Patents
50+
Global OEM/ODM brand and channel partners
Partners
99.2%
Batch quality pass rate through end-to-end QC traceability
Quality Pass Rate

Product Portfolio

Three core product lines

Built on the synthetic biology exosome platform, Aoweisi covers both ToC retail brand lines and ToB biological materials for institutional partners.

Manufacturing

End-to-end OEM and ODM
manufacturing solutions

From formulation development and lyophilization to brand packaging, Aoweisi provides OEM and ODM manufacturing services covering the full product lifecycle for global brands and channel clients. Our platform supports high customization, flexible MOQ, and shorter time-to-market with lower development risk.

01

Custom Formulation Development

Full custom formulation design from exosome concentration and carrier system to excipient combination, aligned to client brand positioning and target indications.

02

Lyophilization & Stabilization

Advanced lyophilization preserves exosome bioactivity under ambient conditions, achieving 18+ months stability without cold-chain dependency.

03

Quality Standards & Certification

Assist clients in establishing product quality specifications and testing standards, supporting domestic and international market registration and regulatory compliance.

04

Brand Packaging & Visual Design

Complete packaging customization from structural design to brand visual identity system, tailored for different channels and market requirements.

05

Pilot Batches & Scale-up Manufacturing

Supports flexible transition from small pilot batches (low MOQ) to full commercial-scale production, shortening time from finalized formula to market launch.

06

Ongoing Technical Support & Iteration

Post-launch support including performance tracking, formulation iteration, and scientific literature backing to help clients continuously strengthen product competitiveness.

Technology Platform

Synthetic biology exosome platform

Unlike purely nature-derived exosome approaches, Aoweisi applies synthetic biology to engineer exosomes for full control from production consistency to application targeting.

Capability 01

Engineered Exosome Design & Targeted Delivery

Synthetic biology engineering of exosomes for precise tissue targeting, enabling efficient local delivery of active factors to skin, mucosal, and airway target tissues.

Capability 02

Lyophilization & Formulation Consistency

Proprietary lyophilization process stabilizes exosome bioactivity at 98.6% retention under ambient storage, eliminating cold-chain dependency and reducing logistics cost and compliance burden.

Capability 03

End-to-End QC Traceability & Batch Consistency

Full-chain QC traceability from raw materials to finished product, combined with intra- and inter-batch consistency management, delivering a 99.2% factory quality pass rate.

Development Path

From platform to market

Aoweisi has built a clear development path around technology maturation, product line completion, and global OEM/ODM service network establishment.

Company established, introducing cutting-edge U.S. life science technology for China application transfer; synthetic biology exosome confirmed as core technology path; three product lines initiated
Exosome engineering platform built; lyophilization process optimized to 98.6% bioactivity retention
AOWEISI SKIN, FEM, and AIR brought into unified brand architecture and OEM/ODM service framework
End-to-end OEM/ODM manufacturing and co-development channels opened to global brands, channel clients, and research partners

Partnership Channels

Multiple collaboration channels

Whether you are a brand seeking OEM/ODM manufacturing, a research institution for joint study, or a channel client, Aoweisi offers dedicated collaboration pathways.

Brands / Channel Clients

OEM / ODM Manufacturing

Full-chain OEM/ODM manufacturing from custom formulation to brand packaging. Flexible MOQ and shortened time-to-market.

Research Institutions

Joint R&D & Technology Licensing

Structured entry points for joint studies around exosome platform technology, indication validation, and clinical translation.

Media / KOL / Communications

Content & Communications

For health content creators, media outlets, and KOLs seeking scientifically grounded brand communication and content collaboration.

Next Step

Explore our research system or start an OEM/ODM partnership conversation

Aoweisi offers a unified public information platform and dedicated partnership channels for brands, research institutions, and channel clients. Whether your next step is understanding the science or opening a manufacturing conversation, we are ready.